Why is "T-cell prolymphocytic leukemia" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-29 08:03:07
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
T-cell-prolymphocytic leukemia (T-PLL) is a mature T-cell leukemia with aggressive behavior and predilection for blood, bone marrow, lymph nodes, liver, spleen, and skin involvement. T-PLL is a very rare leukemia, primarily affecting adults over the age of 30. It represents 2% of all small lymphocytic leukemias in adults. Other names include T-cell chronic lymphocytic leukemia, "knobby" type of T-cell leukemia, and T-prolymphocytic leukemia/T-cell lymphocytic leukemia.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Epidemiology and survival of patients with T-cell prolymphocytic leukemia | Blood Cancer Journal - Nature
-
SELLAS Life Sciences to Present In Vivo Preclinical Data Demonstrating Statistically Significant Survival Benefit of SLS009 in T-Cell Prolymphocytic Leukemia at the European Society for Medical Oncology (ESMO) Congress 2025 - Yahoo Finance
-
Study Reveals Promising Combination Therapy for T-Cell Prolymphocytic Leukemia - Dana-Farber Cancer Institute
-
Disseminated Cryptococcosis With Prostate Involvement in a Patient With T-cell Prolymphocytic Leukemia and Prostate Cancer - Cureus
-
Cytoplasmic Blebs in T-Cell Prolymphocytic Leukemia - The New England Journal of Medicine
-
Advances in Cellular Therapy for T-Cell Prolymphocytic Leukemia - Frontiers
-
T-cell prolymphocytic leukemia | Drozd-Sokołowska | Acta Haematologica Polonica - Via Medica Journals
-
Immunotherapy and epigenetic therapy combination treatment sends T-cell prolymphocytic leukemia into remission - Oncology Central
-
T-cell prolymphocytic leukemia: Epidemiology and survival trends in the era of novel treatments - Wiley Online Library
-
Adult T-Cell Lymphoma: Pharmacologic Management - cancertherapyadvisor.com
-
Review Lays Out the Tough Task of Discerning T-cell Prolymphocytic Leukemia - ajmc.com
-
Clinically and genetically atypical T-cell prolymphocytic leukemia underlines the relevance of a multidisciplinary diagnostic approach - Haematologica
-
Dual STAT3/STAT5 inhibition as a novel treatment strategy in T-prolymphocytic leukemia - Nature
-
Advanced Pathogenetic Concepts in T-Cell Prolymphocytic Leukemia and Their Translational Impact - Frontiers
-
Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-cell prolymphocytic leukemia - Wiley
-
B-cell Prolymphocytic Leukemia: Case Report and Challenges on a Diagnostic and Therapeutic Forefront - Cureus
-
Epigenetic alteration contributes to the transcriptional reprogramming in T-cell prolymphocytic leukemia - Nature
-
Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia - Nature
-
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia - Blood Cancer Journal - Nature
-
Recurrent JAK1 and JAK3 somatic mutations in T-cell prolymphocytic leukemia - Nature
-
T‐PLL Presenting with an Indolent Course - Thammahong - 2024 - Case Reports in Hematology - Wiley Online Library
-
Prognostic significance of cytogenetic abnormalities in T‐cell prolymphocytic leukemia - Wiley Online Library
-
Dual-Targeted Therapy With Ruxolitinib and Duvelisib: Optimizing Treatment for T-Cell Lymphomas Through Pharmacist Collaboration - Pharmacy Times
-
Mature T-Cell leukemias: Challenges in Diagnosis - Frontiers
-
A Rare Case of B-cell Prolymphocytic Leukemia: The First Documented Diagnosis in Georgia With a Comprehensive Literature Review - Cureus
-
Ruxolitinib Appears Effective Across Peripheral T-Cell Lymphoma Subtypes - Hematology Advisor
-
Short telomeres and high telomerase activity in T-cell prolymphocytic leukemia - Nature
-
Obituary information for John "Jay" Schoelermann III - M.B. Kilmer Funeral Home
-
Timothy John Marsh 1948 - 2025 - News-Register
-
Halsey Details ‘Rocky Start’ in Recovery From Lupus, Rare T-Cell Disorder - Rolling Stone Australia
-
The efficacy and safety of the JAK 1/2 inhibitor ruxolitinib in TCL - Lymphoma Hub
-
Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL - Nature
-
Prolymphocytic leukemia: Types, symptoms, treatment, outlook - Medical News Today
-
Alemtuzumab and CHOP for aggressive T-cell lymphoma - Lymphoma Hub
-
Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(1 - Nature
-
Connie Douglas Obituary (1954 - 2023) - Ocean Springs, MS - The Sun Herald - legacy.com
-
A complex pattern of recurrent chromosomal losses and gains in T-cell prolymphocytic leukemia - Wiley Online Library
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.